Grants per year
Personal profile
Research Interests
Dr Nardone’s research focuses on pharmacovigilance and previously undetected and/or undefined drug adverse events and co-morbidities utilizing real world data related to dermatology. As a senior researcher with RADAR (Research on Adverse Drug events And Report) and through the detection of safety signals from “big data “, Dr Nardone effectively conducts data mining that utilizes various data sources, including the FDA and other national database as well as electronic health records, to report new associations that reflect serious adverse events and comorbidities relatable to dermatology practice. Another important dimension to her research focus is the use of state of the art non-invasive instrumentation to augment the diagnostic capabilities of the dermatologist, including, among others, dermoscopy, capillaroscopy and confocal reflectance microscopy technology.
Education/Academic qualification
PhD, University of Catania
… → 2011
MD, University of Catania
… → 2003
Fingerprint Dive into the research topics where Beatrice Nardone is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 7 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants
- 1 Active
Determinants of transdermal drug delivery to the normal and the radiated breast
Blanco Jr, L. Z., Guitart, J., Khan, S. A., Lee, O. & Nardone, B.
2/5/19 → 1/31/24
Project: Research project
Research Output
Current Advances in the Prevention, Risk, and Management of Infection in Patients Receiving Biologic Therapy for Dermatologic Disorders
Kosche, C. A., Ali, Y., Figueiredo, A. C., West, D. P. & Nardone, B., Sep 15 2019, In : Current Dermatology Reports. 8, 3, p. 141-148 8 p.Research output: Contribution to journal › Review article
Frequency of acne in lactose-intolerant adults: a retrospective cross-sectional analysis within a large Midwestern US patient population
Orrell, K. A., Kelm, R. C., Murphrey, M., Nagiredla, S., Wu, B., Abu-Zayed, H., Schlosser, B. J., West, D. P. & Nardone, B., May 1 2019, In : Journal of the European Academy of Dermatology and Venereology. 33, 5, p. e190-e191Research output: Contribution to journal › Letter
Hyperkalemia in women with acne exposed to oral spironolactone: A retrospective study from the RADAR (Research on Adverse Drug Events and Reports) program
Thiede, R. M., Rastogi, S., Nardone, B., Sadowsky, L. M., Rangel, S. M., West, D. P. & Schlosser, B. J., Jul 2019, In : International Journal of Women's Dermatology. 5, 3, p. 155-157 3 p.Research output: Contribution to journal › Article
Open Access
2
Scopus
citations
Incidence of cutaneous adverse events after exposure to tenofovir–emtricitabine in HIV-uninfected vs HIV-infected patients: pharmacovigilance within a large Midwestern U.S. patient population from the Research on Adverse Drug events And Reports program
Kosche, C., Para, A., Brieva, J., West, D. P., Palella, F. J. & Nardone, B., Dec 1 2019, In : Journal of the European Academy of Dermatology and Venereology. 33, 12, p. e470-e471Research output: Contribution to journal › Letter
Melanoma subsequent to natalizumab exposure: A report from the RADAR (Research on Adverse Drug events And Reports) program
Kelm, R. C., Hagstrom, E. L., Mathieu, R. J., Orrell, K. A., Serrano, L., Mueller, K. A., Laumann, A. E., West, D. P. & Nardone, B., Mar 2019, In : Journal of the American Academy of Dermatology. 80, 3, p. 820-821 2 p.Research output: Contribution to journal › Article
2
Scopus
citations